Yale-led research explains why many cancer drugs fail during clinical trial testing
Uncovering the mechanisms behind a mischaracterized drug could shed light on its poor performance in clinical trials, research suggests.
Stay updated with breaking news from Jason Sheltzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Uncovering the mechanisms behind a mischaracterized drug could shed light on its poor performance in clinical trials, research suggests.
According to study, cancer cells with additional chromosomes rely on those chromosomes for tumour formation.
The study states that cancer cells rely on chromosomes for tumour formation - this can be prevented by removing the chromosome from the cancer cells. | Health
According to a recent Yale study, cancer cells with additional chromosomes rely on those chromosomes for tumour formation, and removing them stops the
Many cancer cells have too many chromosomes. A new study reveals their role in promoting cancer — and their potential as a new target for treatment.